Many thanks to Dr. Eoin Flanagan joining our December 2024 AEA Provider Monthly Education Series and presenting Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).
Dr. Flanagan’s session achieves the following:
Review relevant references for the session:
1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar; 22 (3):268-282 Epub 2023 Jan 24 PMID: 36706773
2. Flanagan EP, Tillema JM. Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD): Clinical features and diagnosis. 2022 UpToDate, Waltham, MA.
3. Cacciaguerra L, Flanagan EP. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders. Neurol Clin. 2024 Feb; 42 (1):77-114 Epub 2023 Aug 07 PMID: 37980124 PMCID: PMC10658081 DOI: 10.1016/j.ncl.2023.06.009
The AEA Monthly Didactic + Case Discussion series benefits greatly from the invaluable contributions of our committed autoimmune encephalitis experts. These professionals volunteer their precious time, sharing their profound wisdom and enriching our understanding. Their expertise not only enhances our knowledge but also makes a measurable impact on everyone present. We sincerely acknowledge their contributions.
Learn more about Dr. Flanagan.
Learn more about the AEA Provider Monthly Didactic + Case Discussion Series.
Click here and FILTER BY “AEA Monthly Didactic” to access all didactic recordings.